Science Community Must Reexamine Its Own 'Contract With America'

As the new Republican majority takes its place in Congress, we're beginning to see a fundamental questioning of a wide range of basic assumptions about how our government works. For example, I anticipate a serious examination of exactly what taxpayers should expect from the "technical experts"--scientists and engineers--whose research they fund. So, as one of those engineers, I propose that we must be prepared for that examination with a clear and honest account of our reasons for expecting su

Written byEarl Dowell
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

So, as one of those engineers, I propose that we must be prepared for that examination with a clear and honest account of our reasons for expecting support. And, in fact, we should be prepared to forge a new social contract between us and our clients, the taxpayers--our own "Contract with America."

Given that so much--the nation's economy, health, environment--depends on trust and candor between these two groups, perhaps we should seek a breakthrough in understanding one another to rival the breakthroughs in our laboratories.

First, we should be prepared to admit that the public's "technical experts"--scientists and engineers--have basically been telling a few little white lies to their clients.

For one thing, we must admit that we do have some selfish reasons for wanting to do research supported by public tax dollars. Our explorations are fun and exciting, and we enjoy the deep satisfaction of knowing that our work ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies